Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health
NCT ID: NCT05721014
Last Updated: 2024-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
194 participants
INTERVENTIONAL
2021-10-04
2024-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be randomised to either treatment arm A (OsteoStrong) or treatment arm B (Individually Adapted and Combined Training). Participants in both groups will train for nine months. Treatment arm A will train individually once a week and treatment arm B will train in a group twice a week. Both groups will have a training instructor who will supervise and give training instructions.
Researchers will compare the groups to see the effects of the training methods on the participants' bone health among other outcome measures. The participants will be tested at baseline and post-intervention (9 months later).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis
NCT07267325
The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture
NCT02781974
EFFECT OF FLOW RESTRICTION ON BONE QUALITY WITHIN A MULTICOMPONENT EXERCISE PROGRAM FOR OLDER WOMEN WITH OSTEOPOROSIS.
NCT04760145
SB: Promoting Bone Health in Women
NCT06843486
The Effect of Exercise in Postmenopausal Women with Low Bone Density
NCT00643331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OsteoStrong
Training following the OsteoStrong-method.
OsteoStrong
This training method is an isometric high-impact loading in four different training machines (Spectrum) and balance training on a vibration plate. The four machines are "chest press", "leg press", "pull-down" and "deadlift". The participants press and/or pull isometrically for around 10-15 seconds 1-3 times on every machine.
The training session takes around 20 minutes and is performed individually by the participants with the help of a training instructor.
Individually Adapted and Combined Physical Training
Training based on current recommendations on exercise for people with osteoporosis.
Individually Adapted and Combined Physical Training
This training method is based on the current recommendations on physical activity for people with osteoporosis.
The training is divided into two training sessions:
Circuit training with ten stations with different exercises for the whole body (strength, balance, endurance, weight-bearing). The participants spend 40 seconds on each station. This is repeated during 40 minutes. The training session starts with a joint warm-up and ends with a cool-down.
Strength training with machines for the whole body with the intensity of up to 70-80 % of one repetition max (1RM). The training session starts with a joint warm-up and and a voluntary individual cool-down.
The training session takes around 60 minutes and is performed in a group with the help of a training instructor. The participants also have the option to do a home based exercise programme that they could do in a few cases when they were unable to attend the physical group training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OsteoStrong
This training method is an isometric high-impact loading in four different training machines (Spectrum) and balance training on a vibration plate. The four machines are "chest press", "leg press", "pull-down" and "deadlift". The participants press and/or pull isometrically for around 10-15 seconds 1-3 times on every machine.
The training session takes around 20 minutes and is performed individually by the participants with the help of a training instructor.
Individually Adapted and Combined Physical Training
This training method is based on the current recommendations on physical activity for people with osteoporosis.
The training is divided into two training sessions:
Circuit training with ten stations with different exercises for the whole body (strength, balance, endurance, weight-bearing). The participants spend 40 seconds on each station. This is repeated during 40 minutes. The training session starts with a joint warm-up and ends with a cool-down.
Strength training with machines for the whole body with the intensity of up to 70-80 % of one repetition max (1RM). The training session starts with a joint warm-up and and a voluntary individual cool-down.
The training session takes around 60 minutes and is performed in a group with the help of a training instructor. The participants also have the option to do a home based exercise programme that they could do in a few cases when they were unable to attend the physical group training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vaccinated against Covid-19.
* Be able to participate in nine months of training.
* Untreated with Osteoporosis-medications, or have an ongoing treatment since at least one year back.
Exclusion Criteria
* Ongoing treatment with Osteoporosis-medications that has been delayed for more than eight months for Denosumab, or more than 18 months for bisphosphonates.
* Vertebral fracture, that have been diagnosed within three months.
* Vertebral fracture or hip fracture, that have not previously been treated with Osteoporosis-medications or been assessed by a physician.
* Bilateral hip replacements.
* Symptomatic disc herniation, inguinal herniation or umbilical herniation.
* Untreated hypertension.
* Other diseases that can affect the results and participation in the study: malignant diseases, muscle dystrophy, secondary osteoporosis, or other conditions that would hinder study participation.
* Ongoing treatment with oral cortisone pills (≥ 5 mg Prednisolone).
* Conditions that hinders the conduction of impact microindentation with OsteoProbe: large edema, skin infection, allergy towards local anaesthetics.
* Ongoing or previous training (within the last year) at OsteoStrong.
65 Years
79 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
The Swedish School of Sport and Health Sciences
OTHER
Linkoeping University
OTHER_GOV
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helena Salminen
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena Salminen, Ass. prof.
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet - Department of Neurobiology, Care Sciences and Society: Division of Family medicine and Primary care
Huddinge, Stockholm County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
The website for the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-04359 Osteostrong
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.